Insider Stock Trading History of Dilly Stephen George


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Dilly Stephen George since year 2005. The trader's CIK number is 1389147. At the time of this reporting, Dilly Stephen George is the President and CEO of Aimmune Therapeutics, Inc. . (stock ticker symbol AIMT). See this page for all insider trading activities at Aimmune Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Dilly Stephen George since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-06-11 AIMT Aimmune Therapeutics, Inc. Option Ex 29,457 3.02 89,019
2018-06-11 AIMT Aimmune Therapeutics, Inc. Sale 29,457 30.84 908,306
2018-06-08 AIMT Aimmune Therapeutics, Inc. Sale 42,106 30.70 1,292,527
2018-06-07 AIMT Aimmune Therapeutics, Inc. Sale 32,598 31.26 1,019,111
2018-06-08 AIMT Aimmune Therapeutics, Inc. Option Ex 42,106 3.02 127,244
2018-06-06 AIMT Aimmune Therapeutics, Inc. Sale 30,465 31.20 950,386
2018-06-07 AIMT Aimmune Therapeutics, Inc. Option Ex 32,598 3.02 98,511
2018-06-06 AIMT Aimmune Therapeutics, Inc. Option Ex 30,465 3.02 92,065
2018-06-01 AIMT Aimmune Therapeutics, Inc. Sale 61,197 32.89 2,012,708
2018-06-04 AIMT Aimmune Therapeutics, Inc. Option Ex 65,352 3.02 197,493
2018-06-05 AIMT Aimmune Therapeutics, Inc. Option Ex 38,825 3.02 117,329
2018-06-04 AIMT Aimmune Therapeutics, Inc. Sale 65,352 32.29 2,110,346
2018-06-05 AIMT Aimmune Therapeutics, Inc. Sale 38,825 31.83 1,235,838
2018-06-01 AIMT Aimmune Therapeutics, Inc. Option Ex 61,197 3.02 184,937
2017-10-23 AIMT Aimmune Therapeutics, Inc. Sale 100,000 34.83 3,483,100
2017-10-16 AIMT Aimmune Therapeutics, Inc. Sale 1,154 26.24 30,278
2017-10-04 AIMT Aimmune Therapeutics, Inc. Sale 80,110 26.24 2,101,765
2017-10-05 AIMT Aimmune Therapeutics, Inc. Sale 14,689 26.24 385,498
2017-10-06 AIMT Aimmune Therapeutics, Inc. Sale 4,047 26.31 106,468
2017-09-25 AIMT Aimmune Therapeutics, Inc. Sale 100,000 25.01 2,500,800
2017-07-26 AIMT Aimmune Therapeutics, Inc. Sale 50,000 21.46 1,073,100
2017-06-23 AIMT Aimmune Therapeutics, Inc. Sale 49,400 20.21 998,571
2017-05-10 AIMT Aimmune Therapeutics, Inc. Sale 600 20.15 12,090
2016-11-10 AIMT Aimmune Therapeutics, Inc. Sale 1,304 25.00 32,600
2016-11-11 AIMT Aimmune Therapeutics, Inc. Sale 48,696 25.01 1,217,984

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dilly Stephen George (President and CEO of Aimmune Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.